salicylaldehyde isonicotinoyl hydrazone has been researched along with clioquinol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, F; Ji, Y; Zhou, B | 1 |
1 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and clioquinol
| Article | Year |
|---|---|
Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
Topics: A549 Cells; Aldehydes; Antineoplastic Agents; Apoptosis; Cations, Divalent; Cell Survival; Clioquinol; Copper; Drug Design; Electrochemical Techniques; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrazones; Ionophores; Iron Chelating Agents; Mitochondria; Organ Specificity; Oxidation-Reduction; Reactive Oxygen Species; Structure-Activity Relationship | 2018 |